Synthèse et structure de borates hydratés et anhydres (Rb, Cs, Tl), de borates mixtes (Ba et Li, Sr et Li, Ba et Na, Li et In) et d'un vanadoborate Na3 [B6O9 (VO4)]

AMIENS-BU Sciences (800212103) / SudocSudocFranceF

Détermination de la réactivité électrochimique vis-à-vis du lithium de matériaux d'électrode de type axydes, sulfures et borates métalliques

AMIENS-BU Sciences (800212103) / SudocSudocFranceF

Détermination de la réactivité électrochimique vis-à-vis du lithium de matériaux d'électrode de type axydes, sulfures et borates métalliques

AMIENS-BU Sciences (800212103) / SudocSudocFranceF

More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke

International audienceBACKGROUND: Whether a strategy to target an LDL (low-density lipoprotein) cholesterol 50% from baseline rather than 50% LDL cholesterol reduction from baseline during the trial had a higher baseline LDL cholesterol and a lower LDL cholesterol achieved as compared to patients who had 50% LDL reduction had a significant reduction in the primary outcome as compared to the higher target group (hazard ratio, 0.61 [95% CI, 0.43–0.88]; P =0.007) and patients with <50% LDL reduction from baseline had little reduction (hazard ratio, 0.96 [95% CI, 0.73–1.26]; P =0.75). CONCLUSIONS: In this post hoc analysis of the TST trial, targeting an LDL cholesterol of <70 mg/dL reduced the risk of primary outcome compared with 100±10 mg/dL provided LDL cholesterol reduction from baseline was superior to 50%, thereby suggesting that the magnitude of LDL cholesterol reduction was as important to consider as the target level to achieve. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01252875. URL: https://clinicaltrialsregister.eu ; Unique identifier: EUDRACT2009-A01280-57.gov; Unique identifier: NCT01252875. URL: https://clinicaltrialsregister.eu; Unique identifier: EUDRACT2009-A01280-57.URL: https://www